Electrophysiologic, Cardiohemodynamic and β-Blocking Actions of a New Ultra-Short-Acting β-Blocker, ONO-1101, Assessed by the In Vivo Canine Model in Comparison with Esmolol-Reference-Cited by-同舟云学术

Electrophysiologic, Cardiohemodynamic and β-Blocking Actions of a New Ultra-Short-Acting β-Blocker, ONO-1101, Assessed by the In Vivo Canine Model in Comparison with Esmolol

Published:1999-07 Issue:1 Volume:34 Page:70-77
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Sugiyama Atsushi,Takahara Akira,Hashimoto Keitaro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference26 articles.

1. Development of a Highly Cardioselective Ultra Short-Acting .BETA.-Blocker, ONO-1101.

2. Time Course of a New Ultrashort-Acting β-Adrenoceptor-Blocking Drug, ONO-1101: Comparison with Those of Esmolol and Propranolol by Using the Canine Isolated, Blood-Perfused Heart Preparations

3. Propranolol in the Treatment of Acute Myocardial Infarction

4. Basic pharmacology of esmolol

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landiolol for heart rate control in patients with septic shock and persistent tachycardia A multicenter Randomized Clinical Trial (Landi-SEP);2024-03-18

2. Association Between Intraoperative Landiolol Use and In-Hospital Mortality After Coronary Artery Bypass Grafting: A Nationwide Observational Study in Japan;Anesthesia & Analgesia;2023-10-18

3. Haemodynamic effects of acute intravenous landiolol in Takotsubo cardiomyopathy with dynamic left ventricular outflow tract obstruction;BMJ Case Reports;2023-10

4. Electropharmacological Characterization of Licorice Using the Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Sheets and the Chronic Atrioventricular Block Dogs;Cardiovascular Toxicology;2023-05-30

5. Esmolol (soft drug design);Overcoming Obstacles in Drug Discovery and Development;2023